Books by "John F. Keaney Jr."
3 books found
Interest in green chemistry and clean processes has grown so much in recent years that topics such as fluorous biphasic catalysis, metal organic frameworks, and process intensification, which were barely mentioned in the First Edition, have become major areas of research. In addition, government funding has ramped up the development of fuel cells and biofuels. This reflects the evolving focus from pollution remediation to pollution prevention. Copiously illustrated with more than 800 figures, the Third Edition provides an update from the frontiers of the field. It features supplementary exercises at the end of each chapter relevant to the chemical examples introduced in each chapter. Particular attention is paid to a new concluding chapter on the use of green metrics as an objective tool to demonstrate proof of synthesis plan efficiency and to identify where further improvements can be made through fully worked examples relevant to the chemical industry. NEW AND EXPANDED RESEARCH TOPICS Metal-organic frameworks Metrics Solid acids for alkylation of isobutene by butanes Carbon molecular sieves Mixed micro- and mesoporous solids Organocatalysis Process intensification and gas phase enzymatic reactions Hydrogen storage for fuel cells Reactive distillation Catalysts in action on an atomic scale UPDATED AND EXPANDED CURRENT EVENTS TOPICS Industry resistance to inherently safer chemistry Nuclear power Removal of mercury from vaccines Removal of mercury and lead from primary explosives Biofuels Uses for surplus glycerol New hard materials to reduce wear Electronic waste Smart growth The book covers traditional green chemistry topics, including catalysis, benign solvents, and alternative feedstocks. It also discusses relevant but less frequently covered topics with chapters such as "Chemistry of Long Wear" and "Population and the Environment." This coverage highlights the importance of chemistry to everyday life and demonstrates the benefits the expanded exploitation of green chemistry can have for society.
One of the major biomedical triumphs of the post-World War II era was the defmitive demonstration that hypercholesterolemia is a key causative factor in atherosclerosis; that hypercholesterolemia can be effectively treated; and that treatment significantly reduces not only coronary disease mortality but also all cause mortality. Treatment to lower plasma levels of cholesterol - primarily low density lipoprotein (LDL) cholesterol - is now accepted as best medical practice and both physicians and patients are being educated to take aggressive measures to lower LDL. We can confidently look forward to important decreases in the toll of coronary artery disease over the coming decades. However, there is still uncertainty as to the exact mechanisms by which elevated plasma cholesterol and LDL levels initiate and favor the progression of lesions. There is general consensus that one of the earliest responses to hypercholesterolemia is the adhesion of monocytes to aortic endothelial cells followed by their penetration into the subendothelial space, where they differentiate into macrophages. These cells, and also medial smooth muscle cells that have migrated into the subendothelial space, then become loaded with mUltiple, large droplets of cholesterol esters . . . the hallmark of the earliest visible atherosclerotic lesion, the so-called fatty streak. This lesion is the precursor of the more advanced lesions, both in animal models and in humans. Thus the centrality of hypercholesterolemia cannot be overstated. Still, the atherogenic process is complex and evolves over a long period of time.